These data indicated that CLK2 deficiency correlated with reduced in vivo tumor growth and prolonged survival, which are regulated by phosphorylation of AKT/FOXO3a and Ki-67 expression as a marker of proliferation. Here, CLK2 is linked to neoplasm.